[Endolymphatic radionuclide adjuvant therapy of melanoma and its side effects on the cellular immune system].
D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000528:radiation effects*; D007272:Injections, Intralymphatic; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000401:mortality / Q000532:radiotherapy*; D008875:Middle Aged; D010761:Phosphorus Radioisotopes / Q000008:administration & dosage*; D011878:Radiotherapy / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000276:immunology / Q000401:mortality / Q000532:radiotherapy*
D010761:Phosphorus Radioisotopes
Zur endolymphatischen Radionuklid-Zusatztherapie des Melanoms und deren Nebenwirkungen auf das zelluläre Immunsystem.